APW
VRCA icon

Allied Private Wealth’s Verrica Pharmaceuticals VRCA Stock Holding History

Allied Private Wealth’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34K Buy
+202
New +$1.26K ﹤0.01% 778

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allied Private Wealth's VRCA Position: Q2 2026 in Review

Allied Private Wealth opened a new position in Verrica Pharmaceuticals (VRCA) in Q2 2026: 202 shares worth $1.34K. The stake represents ﹤0.01% of the portfolio and ranks #778 among its holdings.

43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Allied Private Wealth held 202 shares of Verrica Pharmaceuticals worth $1.34K as of Q2 2026.
  • Verrica Pharmaceuticals was a new Allied Private Wealth position in Q2 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of Allied Private Wealth's portfolio in Q2 2026, its #778 holding.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Allied Private Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.